Angel syndicate · 1 deal
Every published round LX Health took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted, and a place in one of its own programs is under Cohorts.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| GenAqua | Pre-seed | Dec 2025 | $300k | Participant | Startup Daily, SmartCompany |
Everyone LX Health has named to a program in published coverage. A place in a program is not a raise: the cheque is the figure recorded with the place, which is the program's standard terms where we hold them, and a blank is one we don't.
| Member | Program | Announced | Cheque | Sources |
|---|---|---|---|---|
| GenAqua | LuminaX Accelerator | 2025 | - | Startup Daily, SmartCompany |
Companies LX Health has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| GenAqua | 2025, Accelerator | 2 | 1 |
Fund closes reported for LX Health, as distinct from the investments it has made.
Companies LX Health has backed that another company then bought. An exit for the holding, not a deal LX Health did.
Stories naming LX Health. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.